selexipag 0.4 MG Oral Tablet [Uptravi]

RxCUI: 1729057
RxNorm name: selexipag 0.4 MG Oral Tablet [Uptravi]
Display name: selexipag 0.4 MG Oral Tablet [Uptravi]
Full name: selexipag 0.4 MG Oral Tablet [Uptravi]
Term type: SBD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:13

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
UPTRAVI	SELEXIPAG	Actelion Pharmaceuticals US, Inc.	a7a23b87-f892-4e2c-8e2e-ebf841220f90	2026-05-28	Warnings, Adverse reactions	Exact identifier rxcui: 1729057

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
a7a23b87-f892-4e2c-8e2e-ebf841220f90	selexipag 0.4 MG Oral Tablet [Uptravi]	SBD	26	These highlights do not include all the information needed to use UPTRAVI safely and effectively. See full prescribing information for UPTRAVI. UPTRAVI ® (selexipag) tablets, for oral use UPTRAVI ® (selexipag) for injection, for intravenous use Initial U.S. Approval: 2015	20260528
a7a23b87-f892-4e2c-8e2e-ebf841220f90	Uptravi 400 MCG Oral Tablet	SY	26	These highlights do not include all the information needed to use UPTRAVI safely and effectively. See full prescribing information for UPTRAVI. UPTRAVI ® (selexipag) tablets, for oral use UPTRAVI ® (selexipag) for injection, for intravenous use Initial U.S. Approval: 2015	20260528
a7a23b87-f892-4e2c-8e2e-ebf841220f90	Uptravi 400 MCG Oral Tablet	PSN	26	These highlights do not include all the information needed to use UPTRAVI safely and effectively. See full prescribing information for UPTRAVI. UPTRAVI ® (selexipag) tablets, for oral use UPTRAVI ® (selexipag) for injection, for intravenous use Initial U.S. Approval: 2015	20260528
a7a23b87-f892-4e2c-8e2e-ebf841220f90	Uptravi 0.4 MG Oral Tablet	SY	26	These highlights do not include all the information needed to use UPTRAVI safely and effectively. See full prescribing information for UPTRAVI. UPTRAVI ® (selexipag) tablets, for oral use UPTRAVI ® (selexipag) for injection, for intravenous use Initial U.S. Approval: 2015	20260528